Supplementary Online Content
|
|
- Elwin Price
- 5 years ago
- Views:
Transcription
1 Supplementay Online Content Lewis JD, Habel LA, Quesenbey CP, et al.pioglitazone use and isk of bladde ca and othe common cas in pesons with diabetes. JAMA. doi:10.11/jama Supplemental Methods. etable 1. Bladde ca stage by pioglitazone teatment etable 2. Hazad Ratios and Confide Intevals fo All Vaiables Included in the Analysis of Eve Exposue to Pioglitazone and the Risk of Bladde Caa: Kaise Pemanente Nothen Califonia Diabetes Registy etable 3. Hazad Ratios a Assessing the Association between Pioglitazone Teatment and Bladde Ca Risk by Sex and Smoking Status: Kaise Pemanente Nothen Califonia Diabetes Registy etable 4. Analysis of Bladde Ca Risk and Duation of Exposue to Pioglitazone with Altenative Categoies of Exposue Including the Categoies Used in the Pio Repot of this Cohot among 193,099 Patients: Kaise Pemanente Nothen Califonia Diabetes Registy etable 5. Analysis of Bladde Ca Risk and Duation of Diabetes Theapies among the 59,070 Patients Who Wee Newly Diagnosed with Diabetes at Cohot Enty: a Kaise Pemanente Nothen Califonia Diabetes Registy etable 6. Sensitivity Analysis of Bladde Ca Risk and Pioglitazone Exposue Censoing FollowUp If Pioglitazone Was Discontinued fo at Least 1 Yea: Kaise Pemanente Nothen Califonia Diabetes Registy etable 7. Sensitivity Analysis of Bladde Ca Risk and Pioglitazone Exposue Using Fine Gadation of the Oldest Age Categoy:a Kaise Pemanente Nothen Califonia Diabetes Registy etable 8. Sensitivity Analysis of Bladde Ca Risk and Pioglitazone Exposue Using Altenative FollowUp Peiods and Altenative Methods to Calculate Cumulative Dose and Duation: Kaise Pemanente Nothen Califonia Diabetes Registy etable 9. Compaison of Suvey Respondents and NonRespondents by CaseContol Status in Nested CaseContol Study of Bladde Ca and Pioglitazone Exposue: Kaise Pemanente Nothen Califonia Diabetes Registy etable 10 Cude of Ca at 10 Sites Accoding to Dose and Duation of Pioglitazone Exposue (n= 236,507)], Kaise Pemanente Nothen Califonia Diabetes Registy, etable 11. Adjusted a Hazad Ratios fo Eve Use of Pioglitazone and othe diabetes medications and Risk of Ca of the Postate, Female Beast, Lung/Bonchus and Colon, nonhodgkin Lymphoma, Copus Utei, Paas, Kidney/Renal Pelvis, and Rectum and Melanoma: Kaise Pemanente Nothen Califonia Diabetes Registy, etable 12. Hazad Ratio a,b Estimates fo the Risk of Ca at 10 sites Associated with Time si Initiation of Pioglitazone, Duation of Pioglitazone Use, and Dose of Pioglitazone used in Sensitivity Analysis 1 [individuals censoed at the time they stop using pioglitazone (n=236,507)], Kaise Pemanente Nothen Califonia Diabetes Registy, etable 13. Hazad Ratio a,b Estimates fo the Risk of Ca at 10 sites Associated with Time si Initiation of Pioglitazone, Duation of Pioglitazone Use, and Dose of Pioglitazone used in Sensitivity Analysis 2 [among individuals with complete infomation on pioglitazone pesciptions (n=196,401)], Kaise Pemanente Nothen Califonia Diabetes Registy,
2 etable 14a. Hazad Ratio a b c Confide Intevals) Estimates fo the Risk of Ca at 10 sites Associated with Time si Initiation of Pioglitazone, Duation of Pioglitazone Use, and Dose of Pioglitazone Used in Sensitivity Analysis 3 [among individuals with additional postal suvey data on height, weight and health behavios (n= 48,425)], Kaise Pemanente Nothen Califonia Diabetes Registy, etable 14b. Hazad Ratio a b c Estimates fo the Risk of Ca at 10 Sites Associated with Time si Initiation of Pioglitazone, Duation of Pioglitazone use, and Dose of Pioglitazone Used in Sensitivity Analysis 3 [among individuals with additional postal suvey data on height, weight and health behavios (n= 48,425)], Kaise Pemanente Nothen Califonia Diabetes Registy, etable 15. Adjusted a Hazad Ratios Confide Intevals) fo Time Si Initiation of Pioglitazone, Duation of Pioglitazone Use, and Dose of Pioglitazone Used and Risk of Ca at 10 Sites Calculating Duation and Dose Stating with the Second Pesciption fo Pioglitazone, Kaise Pemanente Nothen Califonia Diabetes Registy, etable 16. Hazad atios fo the isk of postate ca associated with eve use of pioglitazone, time si initiation, duation, and dose, with and without adjustment fo PSA sceening in the pevious 5 and 3 among a cohot of 123,880 men with diabetes: Kaise Pemanente Nothen Califonia, Januay 1, 1997June 30, 2012 a This supplementay mateial has been povided by the authos to give eades additional infomation about thei wok.
3 BLADDER CANCER STUDY SUPPLEMENTAL METHODS Data Souce The study was conducted within Kaise Pemanente Nothen Califonia (KPNC), which povides compehensive healthcae sevices to appoximately 3.2 million membes, epesenting appoximately 30% of the population in its catchment aea 1. The KPNC phamacy database ecods infomation on each outpatient pesciption dispensed at a KPNC phamacy and includes medication name, dose, egimen, numbe of pills and days supply. Pio eseach demonstated that 80% to 85% of KPNC membes fill all of thei pesciptions at Kaise phamacies; it is appoximately 95% fo those with a phamacy benefit 1. The souce population was identified fom the KPNC diabetes egisty, which was fist constucted in 1993 and has been updated annually si then. The egisty identifies patients pimaily fom fou data souces: pimay hospital dischage oses of diabetes mellitus (si 1971); two o moe outpatient visit oses of diabetes (si 1995); any pesciption fo a diabeteselated medication (si 1994); o any ecod of an abnomal hemoglobin A1c (HbA1c) test (>6.7%) (si 1991). The diabetes egisty gathes data fom a vaiety of KPNC electonic medical ecods (EMR) to build and follow the egisty cohot acoss time. These data include ca egisties, phamacy ecods, laboatoy ecods, and inpatient and outpatient medical oses. These data have been widely employed in pio epidemiological studies 1. Ceation of the Study Cohot The study cohot included both pesons with an established osis of diabetes mellitus pio to Januay 1, 1997 and those who wee newly osed pio to Decembe 31, 22. Patients wee eligible fo the study cohot if they met any of the following citeia: 1) as of Januay 1, 1997 they had been osed with diabetes mellitus, wee age 40 o olde and wee membes of KPNC, 2) they had been osed with diabetes mellitus, eached age 40 between Januay 1, 1997 and Decembe 31, 22 and wee KPNC membes on thei 40th bithday, o 3) had diabetes mellitus and wee age 40 o olde when they joined KPNC between Januay 1, 1997 and Decembe 31, 22. Fom this cohot of 207,378 we then excluded 823 pesons with a osis of bladde ca pio to enty in the cohot o within 6 of joining KPNC in ode to avoid misclassification of pevalent bladde cas as incident oses. Likewise, pesons without pesciption benefits at the time of enty into the cohot (n=6,674) o those with a gap of moe than fou in pesciption o membeship benefits whee the gap stated within the fist fou of enteing the cohot (n=6,782) wee excluded. These pesons would have an extemely limited oppotunity to meet ou exposue definition (descibed below). This esulted in 193,099 eligible men and women with diabetes mellitus, of whom 59,070 wee newly osed with diabetes mellitus between Januay 1, 1997 and Decembe 31, 22. Followup Peiod We included a total of 16 of data extending fom Januay 1, 1997 though Decembe 31, This epot includes an addition of 4 and 8 fom ou published inteim analysis 2. Followup stated on the fist date that the inclusion citeia wee met. Followup fo pesons in the cohot ended when the fist of the following occued: 1) a gap of geate than 4 in eithe membeship o pesciption benefits, 2) a new osis of bladde ca, 3) death fom any cause, o 4) end of followup (Decembe 31, 2012). Outcome The outcome fo this study was an incident osis of bladde ca. nt bladde cas wee identified fom the KPNC ca egisty (one of seveal sites that submit data to the Suveilla, Epidemiology, and End Results [SEER] pogam) fom Januay 1, 1997 to Decembe 31, This was supplemented by case identification though suveilla of electonic pathology epots within KPNC fo the peiod fom Januay 1, 25 to Mach 23, 2012, the time peiod of inteviewing fo the linked nested casecontol study 2. We did not make any distinction egading the histology of the bladde ca and included pesons osed with in situ bladde ca as well as papillay uethal neoplasm of low malignant potential (PUNLMP) fom 25 onwad 3,4. Exposue Definition The pimay exposue of inteest in this study was teatment with pioglitazone, defined as having filled at least two pesciptions fo the dug within a 6month peiod accoding to the KPNC phamacy database. Followup fo eve use began with the second of 2 pesciptions defining eve use such that pesons wee consideed unexposed until the second pesciption was filled. Identical definitions wee used to detemine exposue to othe categoies of diabetes medications. Exposue to pioglitazone and all othe diabetes medications wee teated as unidiectional time dependent vaiables, i.e., o a peson met the exposue definition the peson was consideed exposed fom that point fowad, even if they discontinued the medication. Diabetes medications wee categoized as pioglitazone, othe TZDs, metfomin, sulfonylueas, insulin, and othe (e.g., miglitol and acabose). In addition, indicato vaiables wee ceated sepaately fo pesons who had not eceived any diabetes medication
4 pesciptions and fo those who eceived at least one pesciption but had not met the definition of exposue (i.e., did not fill two pesciptions fo the same medication within a 6month peiod). Each of these was consideed as a sepaate vaiable. Due to the numeous combinations of diabetes medications that ae used by pesons within the cohot and the abse of an a pioi hypothesis that cetain combinations would be moe o less hamful, we did not attempt to ceate vaiables to descibe the diffeent combinations (e.g., sulfonyluea plus pioglitazone). Cumulative duation of exposue was measued by counting the numbe of days between pesciptions. If the next pesciption was filled within 30 days of the expected end date of the pevious pesciption, we assumed that theapy was uninteupted. Howeve, if thee wee no efills within the 30 days afte the expected end date of the pevious pesciption, we assumed a gap in theapy stating 30 days afte the date that the pevious pesciption should have ended (based on days supply vaiable in pesciption database). Cumulative dose of pioglitazone was calculated in a simila fashion. Fo any pesciption that was completed pio to an event date, the total pescibed dose (i.e., numbe of pills in the pesciption multiplied by the dose of the pills) was assumed to have been consumed. Fo pesciptions that wee still active on the date of an event, the total consumed dose was educed to eflect the popotion of pills expected to have been consumed by that date. Potential Confounding Vaiables fo the Cohot Study Fo the cohot study, data on the potential confoundes listed in Table 1 wee extacted fom the EMR. We selected as potential confoundes vaiables believed to be associated with one o moe of the following: the isk of bladde ca (e.g., age, ace, sex, smoking, socioeconomic status), the possibility of detection of bladde ca (e.g., uinay diseases o symptoms including uinay tact infections, uinay incontine, uolithiasis, and pio histoy of othe cas), o the likelihood of being pescibed pioglitazone (e.g., diabetes duation, HbA1c levels, congestive heat failue, and enal insufficiency). Most confoundes othe than smoking wee measued using data ecoded on o befoe the stat of followup. The following vaiables wee teated as time updating covaiates: use of statins, angiotensin conveting enzyme inhibitos o angiotensin ecepto blockes, o medications used to teat benign postatic hypetophy, uinay incontine, uinay tact infection o pyelonephitis, uolithiasis, othe bladde conditions, postatic specific antigen (PSA) testing, HbA1c contation, and complications of diabetes. Complications of diabetes included diabetic etinopathy, peipheal neuopathy, diabetic nephopathy, micoalbuminuia o poteinuia, and coonay atey disease. This vaiable was analyzed both as a composite vaiable and as its individual components. Race was categoized as ecoded in the electonic health ecods. Whee appopiate, categoical vaiables included an additional categoy fo missing data. Although body mass index was poposed as a potential confounde in the potocol, this was not analyzed si the vaiable was missing in appoximately 50% of the pesons. Smoking status was categoized as cuent, not cuent, o missing. Data on smoking have been ecoded in the electonic databases si the middle of Fo pesons who enteed the cohot pio to this time, electonic smoking data is incomplete. To account fo this, we also used data on smoking fom a patient suvey that was completed duing the 1994 to 1996 by membes of the diabetes egisty, which included 65,282 (34%) pesons fom the bladde ca cohot.. Thus, pesons wee categoized as smokes if they wee identified as cuent smokes in the outpatient EMR (14.8%) o by the suvey (3.1%). Patients who wee censoed pio to July 1, 1998, had not completed the suvey, and lacked smoking data in the electonic ecod wee consideed to have missing data on smoking (n=6,905, 3.6%). In the multivaiable analyses descibed below, pesons with missing data on smoking wee gouped with nonsmokes. Analyses excluding pesons with missing smoking data yielded nealy identical esults (data not shown). Similaly, diabetes duation was assessed fom a patient suvey that was completed duing the 1994 to 1996 by membes of the diabetes egisty. Using this souce we obtained diabetes duation at the baseline (o date of enty in the cohot) fo 47,051 (24.4%) people. Fo the emaining people we attempted to calculate diabetes duation at the baseline using the date of enty in the diabetes egisty. We wee able to do so fo the 106,281 (55.0%) diabetes egisty membes who had been in the health plan fo at least two pio to the date of enty in the diabetes egisty. Howeve, fo the emaining 39,778 (20.6%) people who had been in the health plan fo less than two befoe the date of enty in the diabetes egisty, we wee unable to assess diabetes duation. Renal insufficiency was detemined fom measued ceatinine contations. We used the sexspecific theshold levels suggested as a containdication to metfomin theapy to define enal insufficiency ( 1.5 mg/dl in males and 1.4 mg/dl in females) 5. Diabetic nephopathy was defined as a ceatinine contation >2.0 mg/dl fo both men and women. Median annual household income in the census block was used as a measue of socioeconomic status. We dichotomized this measue as high o low, based on whethe the census block median annual household income was above o below the aveage census block median income fo the cohot ($59,0) at the time of the fist inteim analysis. Statistical Analyses fo the Cohot Study Continuous and categoical vaiables wee compaed with the Wilcoxon ank sum test and chisquae test o Fishe s exact test, espectively.
5 Pimay analysis Fo the cohot study, Cox popotional hazads models wee used fo all calculations of the elative hazad (HR) of bladde ca with pioglitazone, adjusted fo the covaiates. The efee goup fo calculation of the elative hazad associated with eve use of pioglitazone was neve use of pioglitazone. Neve use of pioglitazone includes pesons on no diabetes medications, with < 2 fills fo pioglitazone in a 6 month peiod, and with use of medications othe than pioglitazone. Identical methods wee used to detemine elative hazads associated with exposue to othe categoies of diabetes medications. We decided a pioi to include age (categoized as 4049, 5059, 6069, and 70 o olde) and sex in all baseline models, given the known association of these vaiables with iased isk of bladde ca. Calenda yea of cohot enty was included in the baseline model to account fo tends in teatment pattens. Othe categoies of diabetes medications wee included in the baseline model to assess both fo confounding and the association of the othe medications with bladde ca. To test fo confounding, we pefomed analyses that included smoking and othe vaiables measued at baseline in an adjusted Cox egession model. This adjusted model included the following as covaiates: age, sex, ace/ethnicity, yea of cohot enty, othe diabetes medications, smoking, othe bladde conditions, median household income, congestive heat failue, ca othe than bladde ca, enal insufficiency, HbA1c and the inteaction with new osis of diabetes, duation of diabetes. Patients who ae newly osed with diabetes will always have an elevated HbA1c contation but this usually impoves quickly when theapy is initiated. This is diffeent fom a peson who is on teatment and despite this has an elevated HbA1c contation. This latte goup eflects poo contol of diabetes despite theapy. The inteaction tem allows fo this distinction. The fully adjusted model did not include the time updating vaiables, as it was not infeasible to include so many time updating vaiables in a single model. Rathe, we tested each time updating vaiable sepaately by adding the vaiable to the base model to detemine whethe inclusion of the vaiable changed the HR fo the association with pioglitazone by 10% o moe. None of the vaiables esulted in a 10% o geate change, and as such none meet ou definition of confounding. Howeve, the lagest changes in the HR wee seen when the vaiables elated to poteinuia o diabetic nephopathy wee included. Thus, we ceated an additional model that included the vaiables measued at baseline, smoking, and the esults of testing fo micoalbuminuia. As descibed peviously 6, the latte vaiable excluded uine tests that included testing fo hematuia and was categoized as positive, negative, o no testing duing the past yea. Seconday Analysis Assessment of Relation between Pioglitazone Dose and Duation and Bladde Ca Additional analyses wee pefomed to exploe fo evide of an iasing isk of bladde ca with iasing exposue to pioglitazone as compaed to neve use of pioglitazone. We measued exposue in tems of the following: time si initiation of theapy, cumulative dose of pioglitazone, and cumulative duation of theapy. Calculation of the total dose o duation of teatment was computed stating with the fist pesciption that defined eve use of pioglitazone. Each of these vaiables was categoized into thee levels (tetiles) such that we had thee goups of appoximately simila size. The efee goup fo these analyses was neve use of pioglitazone. Test fo effect modification We also examined whethe the association between bladde ca and pioglitazone exposue (eve vs. neve and by duation, dose, and time si initiation of pioglitazone) diffeed accoding to sex o by smoking status. Sex was selected to examine fo effect modification based on the appaent diffee in bladde ca isk among male and female ats teated with pioglitazone. Smoking was selected because of the stong association between smoking and bladde ca isk. Additional pespecified analyses of pesons with complete histoy of dug exposue and association of othe diabetes medications with bladde ca isk An analysis limited to pesons who wee newly osed with diabetes duing the un in peiod fom 1997 to 22. The definition of newly osed diabetes equied that the peson was a membe of KPNC fo a minimum of 2 befoe thei fist diabetes osis. This analysis eliminated the potential fo left censoing. This analysis also allowed us to examine the duation effect of othe medications. Additional post hoc analyses We designed a numbe of post hoc analyses, lagely geaed at undestanding diffees in the 5yea inteim analysis and the 10yea final analysis and checking fo potential bias in ou design. These included the following: 1) An analysis that tuncated followup afte Apil 30, 28 (the end of followup in the published inteim analysis) but used the cuent cut points fo exposue duation. This analysis allowed us to assess whethe small changes in the computational methods o updates to the clinical and ca egisty data could have impacted the esults. 2) An analysis that futhe divided the longest exposue duation categoy into 4.1 to 6 and moe than 6, fully adjusted as in the pimay analyses. This analysis allowed us to assess fo a duation esponse using fine gadation of the
6 duation categoies, whethe those with the longest exposue to pioglitazone had the highest isk of bladde ca, and whethe the smalle hazad atio fo long tem exposue to pioglitazone in the final analysis was unifom acoss all duations of exposue o unique to only those with vey long duation of use. 3) An analysis that censoed followup afte pesons discontinue pioglitazone fo 1 yea. This examined whethe ou design that consideed pesons exposed foeve even if they discontinued theapy could have biased the esults. 4) An analysis that futhe divided the uppe most age categoy into fine goups to account fo potential bias elated to less use of pioglitazone among eldely pesons, fully adjusted as in the pimay analysis. 5) Pioglitazone is typically used only in pesons fo whom fist line theapy with diet and metfomin is inadequate An analysis was completed that excluded the fist 6 afte cohot enty to account fo possible iased detection of bladde ca in those newly osed with diabetes mellitus 7 (etable 8). Patients who eceived one o moe pesciptions fo pioglitazone duing the fist 6 in the cohot wee excluded fom the analysis to avoid immotal time bias. Models wee un in the entie cohot and those who wee newly osed with diabetes duing the followup peiod. 6) In the pimay analysis, dose and duation included the fist pesciption that was pat of the equiement fo two pesciptions within 6 to define eve exposue. This appoach povides a moe accuate estimate of the tue duation of exposue, howeve it also includes a small amount of immotal time when it would not have been possible fo the peson to have developed bladde ca (i.e. had they been osed with bladde ca between the fist and second pesciption, they would have been categoized as a case fo the unexposed cohot). Stating the calculation of dose and duation with the second pesciption eliminates the isk of immotal time bias but povides an inaccuate estimate of the cumulative dose and duation of exposue. To addess this, we epeated the analysis stating the calculation of dose and duation at the time of the 2 nd pesciption that met the definition of exposue (etable 8). Nested casecontol study To account fo incomplete o missing EMR data on ace/ethnicity, smoking histoy, duation of diabetes, and occupational exposues, we supplemented the cohot study with a casecontol study nested within the study cohot. Fom the souce cohot, we identified all incident oses of bladde ca fo the peiod fom Octobe 1, 22 to Mach 23, The index date was defined as the date of bladde ca osis. Fo each individual with bladde ca, one contol was andomly selected afte matching on sex, age ( 2.5 ), and time fom enty into the diabetes egisty to index date (± 6 ). In addition, each contol subject could not have been osed with bladde ca o have been censoed fom the cohot fo othe easons pio to the date of fist osis with bladde ca of the matched case subject. When a contol subject could not be eached fo inteview (see below) o efused to paticipate, additional contol subjects wee selected until a matched contol could be enolled. A minimum of 15 attempts that included a vaiety of days and times wee made to each all cases and contol subjects befoe detemining that the subject was uneachable. The date that the case subject was fist osed with bladde ca seved as the efee date fo both the case subject and fo the matched contol. The additional data fo the casecontol study (e.g., ace/ethnicity, duation of diabetes, smoking, use of indwelling cathetes, fequency of uinay tact infections, and occupational exposues) wee collected up to the efee date though telephone inteviews using a standadized questionnaie administeed by tained inteviewes. The questionnaie was administeed using computeassisted telephone inteviews (CATI) with diect data enty by inteviewe. Fo a small numbe of case subjects who wee unable to complete the full inteview (n=46), a shote inteview was completed by a poxy. Fo 23 of these case subjects, the matched contol subject also completed the shote poxy vesion of the suvey. In 7 cases with full inteviews, the contol had a poxy inteview. In the casecontol study, smoking was categoized accoding to total pack consumed pio to the efee date. Ciga and/o pipe smoking among noncigaette smokes wee combined as a dichotomous vaiable fo having eve smoked 1 o moe cigas o pipes pe week fo six o longe. Duation of diabetes was categoized as less than 5, 6 to 10, moe than 10, and unknown. Pevious and/o cuent employment in pofessions associated with iased bladde ca isk wee teated as dichotomous vaiables. Highisk occupational exposues wee defined as any pio histoy of wok as a painte, dive o haidesse Pevious uinay tact infection was categoized as none, one to two pio infections, o moe than two pio infections. Statistical analyses fo the Nested CaseContol Study We examined the chaacteistics of the paticipants and nonpaticipants in the nested casecontol study using desciptive statistics (etable 9). Analysis of the casecontol study was conducted in a simila fashion as the cohot study except that conditional logistic egession was used to calculate odds atios (ORs) and 95% confide intevals (CIs). Within the casecontol study, potential confoundes that wee deived exclusively fom EMR data wee defined as descibed fo the cohot study (e.g., congestive heat failue was assessed at the stat of followup in the cohot).
7 PROSTATE CANCER SUPPLEMENTAL METHODS To assess the potential fo detection bias seconday to diffeential use of postatespecific antigen (PSA) testing by pioglitazone use, in a post hoc analysis, the isk of postate ca associated with eve use, time si initiation, duation and dose of pioglitazone, was estimated with and without adjustment fo PSA sceening the pevious 5. Similaly, to examine the potential impact of osis with and teatment fo BPH, the isk of postate ca associated with eve use, time si initiation, duation and dose of pioglitazone was estimated with additional adjustment fo BPH teatment [classified as having had a BPH pocedue [i.e., tansuethal esection of the postate (TURP)], dug teatment fo BPH (alpha blocke o 5ARI), had BPH but not teated, o no BPH (efee). Results of these analyses ae included in etable 16. Refees 1. Fiedman G, Habel L, Boles M, et al. Kaise Pemanente Medical Cae Pogam: Division of Reseach, Nothen Califonia, and Cente fo Health Reseach, Nothwest Division. In: Stom BL, ed. Phamacoepidemiology. Thid ed. West Sussex: John Wiley & Sons, Ltd; 20: Lewis JD, Feaa A, Peng T, et al. Risk of bladde ca among diabetic patients teated with pioglitazone: inteim epot of a longitudinal cohot study. Diabetes cae. Ap 2011;34(4): Samaatunga H, Makaov DV, Epstein JI. Compaison of WHO/ISUP and WHO classification of noninvasive papillay uothelial neoplasms fo isk of pogession. Uology. Aug 22;60(2): Cheng L, Neumann RM, Bostwick DG. Papillay uothelial neoplasms of low malignant potential. Clinical and biologic implications. Ca. Nov ;86(10): Glucophage and Glucophage XR (metfomin HCl). Glucophage (metfomin HCl) Tablets and Glucophage XR (metfomin HCl extended elease) Tablets [Full Pescibing Infomation (US only)]. Piton, NJ, Bistol Myes Squibb Company; Lewis JD, Habel L, Quesenbey C, et al. Poteinuia testing among patients with diabetes mellitus is associated with bladde ca osis: potential fo unmeasued confounding in studies of pioglitazone and bladde ca. Phamacoepidemiology and dug safety. Ap Colmes IN, Majumda SR, Yasui Y, Bowke SL, Maa CA, Johnson JA. Detection bias and oveestimation of bladde ca isk in type 2 diabetes: a matched cohot study. Diabetes cae. Oct 2013;36(10): Chen R, Seaton A. A meta analysis of painting exposue and ca motality. Ca Detect. Pev. 1998;22(6): Kunze E, Chang Claude J, Fentzel Beyme R. Life style and occupational isk factos fo bladde ca in Gemany. A casecontol study. Ca. Ap ;69(7): Takkouche B, Regueia Mendez C, Montes Matinez A. Risk of ca among haidesses and elated wokes: a metaanalysis. Int. J. Epidemiol. Sep
8 etable 1. Bladde ca stage by pioglitazone teatment Ca Stage Eve Use of Pioglitazone a Neve Use of Pioglitazone (n=186 Cases) (n=1,075 Cases) PUNLMP b 2 (1%) 11 (1%) In situ 93 (50%) 521 (49%) Local 74 (40%) 409 (38%) Regional 8 (4%) 65 (6%) Distant 3 (2%) 34 (3%) Undetemined 6 (3%) 35 (3%) a Eve use is defined as two pesciptions fo pioglitazone within 6 and was teated as time updating b Papillay uethal neoplasm of low malignant potential
9 etable 2. Hazad Ratios and Confide Intevals fo All Vaiables Included in the Analysis of Eve Exposue to Pioglitazone and the Risk of Bladde Ca a : Kaise Pemanente Nothen Califonia Diabetes Registy All Covaiates Numbe with Chaactei stic Bladde Ca Fully Adjusted HR Diabetes Medications Neve use of Pioglitazone 158,918 1,075 Refee Eve use of Pioglitazone 34, ( ) Neve use of Othe TZDs 187,856 1,223 Refee Eve use of Othe TZDs 5, ( ) Neve use of Metfomin 91, Refee Eve use of Metfomin 101, ( ) Neve use of Insulin 128, Refee Eve use of Insulin 64, ( ) Neve use of Sulfonylueas 65, Refee Eve use of Sulfonylueas 128, ( ) Neve use of Othe oal hypoglycemic agents 188,711 1,240 Refee Eve use of Othe oal hypoglycemic agents 4, ( ) Teated with any diabetes medications 170,426 1,047 Refee Neve teated with any diabetes medications 22, ( ) Teated with any diabetes medications o neve eceived even a single pesciption fo any diabetes medications Received at least one pesciption fo a diabetes medication but neve met the definition of exposue 185,914 1,217 Refee 7, ( ) Sex Female 89, Refee Male 103,248 1, ( ) Age at Cohot Enty Age , Refee Age , ( ) Age , ( ) Age >=70 45, ( ) Cohot Enty Enteed cohot in , Refee Enteed cohot in , ( ) Enteed cohot in , ( ) Enteed cohot in 20 18, ( ) Enteed cohot in 21 25, ( ) Enteed cohot in 22 23, ( )
10 etable 2. Hazad Ratios and Confide Intevals fo All Vaiables Included in the Analysis of Eve Exposue to Pioglitazone and the Risk of Bladde Ca a : Kaise Pemanente Nothen Califonia Diabetes Registy (continued) All Covaiates Numbe with Chaacteistic Bladde Ca Fully Adjusted HR Race Caucasian 1, Refee Black 20, ( ) Asian 25, (0.3.48) Hispanic 21, ( ) Othe ace 11, ( ) Smoking Befoe Censo Date 34, ( ) Any Bladde Conditions on o Pio to 29, ( ) Cohot Enty Median Household Income Below aveage (<$59K) 96, Refee Above aveage (>$59K) 78, ( ) Income census data missing 17, ( ) Histoy of Congestive Heat Failue Absent 181,092 1,176 Refee Pesent 12, ( ) Pio Diagnosis of Ca Othe Than Bladde Ca Absent 183,583 1,168 Refee Pesent 9, ( ) Seum Ceatinine at Cohot Enty Nomal 149, Refee Abnomal 15, ( ) Missing 28, ( ) HbA1c at Cohot Enty <7 51, Refee , ( ) , ( ) , ( ) >=10 35, ( ) Missing 34, ( ) Newly Diagnosed Diabetic 109, ( ) Inteaction Tem HbA1c 77.9 and newly osed diabetic 20, ( ) HbA1c 88.9 and newly osed diabetic 9, ( ) HbA1c 99.9 and newly osed diabetic 6, ( ) HbA1c >=10 and newly osed diabetic 20, ( ) HbA1C missing and newly osed 20, ( ) diabetic Newly Diagnosed Diabetic 109, ( )
11 etable 2. Hazad Ratios and Confide Intevals fo All Vaiables Included in the Analysis of Eve Exposue to Pioglitazone and the Risk of Bladde Ca a : Kaise Pemanente Nothen Califonia Diabetes Registy (continued) All Covaiates Numbe with Chaacteistic Bladde Ca Fully Adjusted HR Diabetes Duation <5 120, Refee 59 12, ( ) , ( ) Missing 39, ( ) Poteinuia Testing No testing 95, Refee Negative test esult 59, ( ) Positive test esult 38, ( ) a Analysis included 1,075 and 186 cases of bladde ca among pioglitazone unexposed and exposed pesons.
12 etable 3. Hazad Ratios a Assessing the Association between Pioglitazone Teatment and Bladde Ca Risk by Sex and Smoking Status: Kaise Pemanente Nothen Califonia Diabetes Registy Peson of followup time unexposed to pioglitazone Peson of followup time eve exposed to pioglitazone Cases of bladde ca among pioglitazone unexposed Cases of bladde ca among pioglitazone exposed Bladde ca incide ate among pioglitazone unexposed (pe peson) Bladde ca incide ate among pioglitazone exposed (pe peson) Men Women Smokes Nonsmokes 740, , ,848 1,146, ,632 98,480 42, , ( ) ( ) 35.5 ( ) 26.0 ( ) ( ) 94.9 ( ) 83.7 ( ) 71.4 ( )
13 etable 3. Hazad Ratios a Assessing the Association between Pioglitazone Teatment and Bladde Ca Risk by Sex and Smoking Status: Kaise Pemanente Nothen Califonia Diabetes Registy (continued) Eve Exposed to Pioglitazone Inteaction p value Time si stating pioglitazone b < >8 Bladde ca (n) Men HR, 95% CI ( ) ( ) ( ) ( ) Bladde ca (n) Wome n HR, 95% CI ( ) ( ) 1.77 ( ) 1.60 ( ) Bladde ca (n) Smoke s HR, 95% CI ( ) ( ) 1.14 ( ) 1.21 ( ) Bladde ca (n) Nonsmoke s HR, 95% CI ( ) ( ) 1.35 ( ) 1.33 ( ) Test fo tend p values Inteaction p c values Duation of Theapy b < > ( ) ( ) ( ) ( ) 0.78 ( ) 1.29 ( ) ( ) 0.99 ( ) 1.17 ( ) ( ) 1.13 ( ) 1.24 ( ) Test fo tend p values Inteaction p c values Cumulative
14 Dose b mg mg >4 mg ( ) ( ) ( ) ( ) 0.62 ( ) 1.28 ( ) ( ) 1.29 ( ) 0.85 ( ) Test fo tend p values Inteaction p c values a Adjusted fo age, sex, and calenda yea of cohot enty b Refee goup is unexposed to pioglitazone c Inteaction p values ae fo the inteaction between the exposue and sex o smoking in the test fo tend analysis ( ) 1.12 ( ) 1.25 ( ) 0.17
15 etable 4. Analysis of Bladde Ca Risk and Duation of Exposue to Pioglitazone with Altenative Categoies of Exposue Including the Categoies Used in the Pio Repot of this Cohot among 193,099 Patients: Kaise Pemanente Nothen Califonia Diabetes Registy Peson Yeas Cases of Bladde Ca Model 1 (HR, 95% Model 2 (HR, 95% Unexposed to Pioglitazone 1,417,196 1,075 Refee Refee Time si Stating Pioglitazone < , ( ) 0.98 ( ) 1.5 to 3 43, ( ) 0.81 ( ) > 3 121, ( ) 1.12 ( ) 3.1 to , ( ) 0.88 ( ) 4.5 to 8 58, ( ) 1.21 ( ) > 8 26, ( ) 1.20 ( ) Duation of Theapy < 1 yea 62, ( ) 0.83 ( ) , ( ) 1.06 ( ) > 2 107, ( ) 1.09 ( ) , ( ) 1.01 ( ) , ( ) 1.29 ( ) > 6 20, ( ) 0.99 ( ) Cumulative dose 1 10,5 mg 78, ( ) 0.92 ( ) 10,501 28,0 mg 63, ( ) 0.87 ( ) >28,0 mg 74, (1.1.62) a 1.23 ( ) 28,1 40,0 mg 24, ( ) 1.53 ( ) >40,0 mg 50, ( ) 1.07 ( ) Model 1 is adjusted fo: age, sex, ace/ethnicity, othe diabetes medications, smoking, othe bladde conditions, median household income, congestive heat failue, ca othe than bladde ca, enal insufficiency, HbA1c and the inteaction with new osis of diabetes, duation of diabetes, and yea of cohot enty Model 2 is adjusted fo all vaiables in model 1 plus the 3level time updated poteinuia testing vaiable (no testing, negative and positive testing fo poteinuia) a Lowe bound of 95% CI is
16 etable 5. Analysis of Bladde Ca Risk and Duation of Diabetes Theapies among the 59,070 Patients Who Wee Newly Diagnosed with Diabetes at Cohot Enty: a Kaise Pemanente Nothen Califonia Diabetes Registy Pioglitazone HR Metfomin HR Sulfonylueas HR Insulin HR N Unexposed 50,024 25,144 19,234 47,346 N Unexposed Cases N Exposed 9,046 33,926 39,836 11,724 N Exposed Cases N Exposed Cases/ N Exposed by End of FollowUp Duation of Theapy <1.5 13/2,589 37/5,760 57/7,448 14/4, /3,198 58/8,229 68/9,564 13/3,730 > 4 9/3,259 72/19, /22,824 11/3,137 Model 1 Eve/Neve Ex posed 0.84 ( ) 0.93 ( ) 0.90 ( ) 0.95 ( ) Duation of Theapy Neve exposed Refee Refee Refee Refee < ( ) 0.81 ( ) 1.01 ( ) 0.67 ( ) ( ) 0.94 ( ) 0.90 ( ) 0.99 ( ) > ( ) 0.90 ( ) 0.73 ( ) 1.49 ( ) Model 2 Duation of Theapy Neve exposed Refee Refee Refee Refee < ( ) 0.82 ( ) 1.01 ( ) 0.70 ( ) ( ) 0.96 ( ) 0.91 ( ) 1.03 ( ) > ( ) 0.93 ( ) 0.75 ( ) 1.53 ( ) a The definition of newly osed with diabetes equied that the peson was a membe of KPNC fo a minimum of 2 befoe the fist diabetes osis. Model 1 Results of age, sex, ace, smoking and calenda yea of cohot enty adjusted models. Model 2 Adjusted fo model 1 vaiables plus each of the othe thee diabetes theapies whee the othe theapy is teated as a time updating vaiable fo neve vesus eve exposed.
17 etable 6. Sensitivity Analysis of Bladde Ca Risk and Pioglitazone Exposue Censoing FollowUp If Pioglitazone Was Discontinued fo at Least 1 Yea: Kaise Pemanente Nothen Califonia Diabetes Registy N Cases of Bladde Ca Fully Adjusted Adding the Poteinuia Testing Vaiable (HR, 95% Unexposed to Pioglitazone Eve Exposed to Pioglitazone 158,918 1,075 Refee 34, ( ) Time si stating pioglitazone <4.5 21, ( ) , ( ) >8 4, ( ) Duation of theapy <1.5 11, ( ) , ( ) >4 11, ( ) Cumulative Dose mg 12, ( ) mg 10, ( ) >4 mg 10, ( )
18 etable 7. Sensitivity Analysis of Bladde Ca Risk and Pioglitazone Exposue Using Fine Gadation of the Oldest Age Categoy: a Kaise Pemanente Nothen Califonia Diabetes Registy Adjusted fo Age, Sex and Yea of Cohot Enty (HR, 95% Fully Adjusted b (HR, 95% Fully Adjusted Adding the Poteinuia Testing Vaiable c (HR, 95% Unexposed to Pioglitazone Refee Refee Refee Eve Exposed to Pioglitazone 1.09 ( ) d 1.10 ( ) 1.06 ( ) Time si Stating Pioglitazone < ( ) 0.94 ( ) 0.89 ( ) (1.1.68) 1.27 ( ) 1.22 ( ) > ( ) 1.24 ( ) 1.20 ( ) Test fo tend p values Duation of Theapy < ( ) 0.94 ( ) 0.89 ( ) ( ) 1.09 ( ) 1.03 ( ) > ( ) 1.19 ( ) 1.16 ( ) Test fo tend p values Cumulative Dose mg 0.95 ( ) 0.95 ( ) 0.90 ( ) mg 1.17 ( ) 1.16 ( ) 1.10 ( ) >4 mg 1.14 ( ) 1.09 ( ) 1.06 ( ) Test fo tend p values a Age categoies wee 4049, 5059, 6069, 7079, 8089, 90 and olde. b Fully adjusted efes to: age, sex, ace/ethnicity, othe diabetes medications, smoking, othe bladde conditions, median household income, congestive heat failue, ca othe than bladde ca, enal insufficiency, HbA1c and the inteaction with new osis of diabetes, duation of diabetes, and yea of cohot enty c Fully adjusted model adding the 3level time updated poteinuia testing vaiable (no testing, negative and positive testing fo poteinuia), excluding same day test fo hematuia d Also adjusted fo use of othe diabetes medication
19 etable 8. Sensitivity Analysis of Bladde Ca Risk and Pioglitazone Exposue Using Altenative FollowUp Peiods and Altenative Methods to Calculate Cumulative Dose and Duation: Kaise Pemanente Nothen Califonia Diabetes Registy Unexposed to Pioglitazone Eve exposed to Pioglitazone Model 1 a (HR, 95% Model 2 a (HR, 95% Model 3 a (HR, 95% Model 4 a (HR, 95% Refee Refee Refee Refee 1.10 ( ) N/A 1.11 ( ) 0.93 ( ) Time si Stating Pioglitazone < ( ) ( ) > ( ) Duation of Theapy < ( ) ( ) > ( ) 0.98 ( ) 1.28 ( ) 1.27 ( ) 1.02 ( ) 1.13 ( ) 1.19 ( ) 0.95 ( ) 1.26 ( ) 1.24 ( ) 0.92 ( ) 1.09 ( ) 1.22 ( ) 0.92 ( ) 0.55 ( ) 1.85 ( ) 0.88 ( ) 0.81 ( ) 0.98 ( ) Cumulative Dose mg 0.94 ( ) 1. ( ) 0.95 ( ) 0.94 ( ) mg 1.15 ( ) 1.27 ( ) 1.15 ( ) 0.96 ( ) >4 mg 1.09 ( ) 1.04 ( ) 1.12 ( ) 0.60 ( ) Model 1 pimay analysis model (i.e. Model 3 in Table 2) Model 2 calculating dose and duation of exposue stating with the second of two pesciptions fo pioglitazone equied to meet the definition of exposue Model 3 stating followup 6 afte cohot enty Model 4 stating followup 6 afte cohot enty among those newly osed with diabetes a Adjusted fo: age, sex, ace/ethnicity, othe diabetes medications, smoking, othe bladde conditions, median household income, congestive heat failue, ca othe than bladde ca, enal insufficiency, HbA1c and the inteaction with new osis of diabetes, duation of diabetes, and yea of cohot enty N/A not applicable
20 etable 9. Compaison of Suvey Respondents and NonRespondents by CaseContol Status in Nested CaseContol Study of Bladde Ca and Pioglitazone Exposue: Kaise Pemanente Nothen Califonia Diabetes Registy Case Paticipant (n=464) Case Refuse (n=119) Age at Refee Date (25.4%) (15.1%) (45.3%) (45.4%) > (25.4%) (34.5%) Sex 70 (15.1%) 20 Case Non Paticipant fo Othe Reason (n=117) Contol Paticipant (n=464) Contol Refuse (n=209) Contol Non Paticipant fo Othe Reason (n=360) 18 (3.9%) 6 (5%) 7 (6%) 19 (4.1%) 4 (1.9%) 9 (2.5%) 28 (23.9%) 126 (27.2%) 58 (27.8%) 71 (19.7%) 38 (32.5%) (38.6%) (45.3%) (37.3%) 44 (37.6%) (39.2%) (23.5%) (33%) 31 (26.5%) 70 (15.1%) (17.5%) (Female) (16.8%) (16.7%) Congestive 21 (4.5%) 12 7 (6%) 13 (2.8%) 8 (3.8%) 16 (4.4%) Heat Failue (10.1%) Elevated 23 (5%) 9 (7.6%) 17 (14.5%) 28 (6%) (8.3%) Ceatinine a (6.2%) Pevalent (12.8%) (25.3%) Case (23.5%) (29.4%) (23.7%) (30.6%) Pioglitazone 91 (19.6%) (22.2%) 81 (17.5%) (13.6%) (10.1%) (20.1%) Othe TZDs 14 (3%) 3 (2.5%) 4 (3.4%) 10 (2.2%) 7 (3.3%) 9 (2.5%) Metfomin (47.9%) (45%) (55.6%) (48.7%) (54.3%) (50.2%) Sulfonyluea (65.8%) (63.6%) (67.5%) (58%) (63.8%) (58.4%) Insulin (30.8%) (18.9%) (23.1%) (26.1%) (26.5%) (23.9%) No Diabetes 71 (15.3%) (15.4%) 66 (14.2%) (18.6%) Medications (18.5%) (20.6%) Cuent 116 (25%) (25.6%) 77 (16.6%) (16.7%) Smoke b (28.6%) (21.1%) a Ceatinine >1.4 fo women and >1.5 fo men b As defined in the cohot study data TZD = Thiazolidinedione
21 etables fo Association of Pioglitazone Exposue and Risk of Risk of Ca of the Postate, Female Beast, Lung/Bonchus and Colon, nonhodgkin Lymphoma, Copus Utei, Paas, Kidney/Renal Pelvis, and Rectum and Melanoma
22 etable 10 Cude of Ca at 10 Sites Accoding to Dose and Duation of Pioglitazone Exposue (n= 236,507)], Kaise Pemanente Nothen Califonia Diabetes Registy, Neve Pioglitazo ne Post ate pe peso n be of ca (3301) Femal e Beas t pe peso n be of ca (2477) Lung/ Bonc hus pe peso n be of ca (2,292 ) Colon NHL Cop us Utei pe peso n be of ca (1841) pe peso n be of ca 57.6 (835) pe peso n be of ca (798) Panc eas pe peso n be of ca 48.4 (647) Kidne y/ Renal Pelvi s pe peso n be of ca 47.3 (685) Rectu m pe peso n be of ca 39.5 (568) Melan oma pe peso n be of ca 40.9 (592) Eve Pioglitazo ne (476) (320) (282) (233) 58.7 (120) (118) 81.1 (164) 53.8 (110) 29.1 (59) 49.9 (102) Time Si Initiation < (55) (42) (32) 68.2 (22) 59.7 (21) (14) (33) 35.3 (12) 24.6 (8) 38.0 (10) (82) (42) (48) 90.4 (30) 77.8 (26) (20) 65.9 (22) 29.9 (10) 24.1 (8) 53.9 (18) (76) (47) (45) (47) 54.1 (16) 94.6 (12) 60.8 (18) 60.8 (18) 37.4 (11) 40.6 (12) (75) (31) (37) 1.6 (26) 46.1 (12) (15) 73.0 (19) 65.3 (17) 46.4 (12) 61.5 (16) (119) (91) (75) (71) 43.4 (24) (36) 74.1 (41) 63.3 (35) 21.9 (12) 43.4 (24) > (69) (67) (45) (37) 70.2 (21) (21) (31) 60.1 (18) 27.0 (8) 73.5 (22)
23 etable 10 Cude of Ca at 10 Sites Accoding to Dose and Duation of Pioglitazone Exposue (n= 236,507)], Kaise Pemanente Nothen Califonia Diabetes Registy, (continued) Post ate pe peso n be of ca Femal e Beas t pe peso n be of ca Lung/ Bonc hus pe peso n be of ca Colon NHL Cop us Utei pe peso n be of ca pe peso n be of ca pe peso n be of ca Panc eas pe peso n be of ca Kidne y/ Renal Pelvis pe peso n be of ca Rectu m pe peso n be of ca Melan oma pe peso n be of ca Duati on of use < 12 month s (118) (88) (83) (72) 52.0 (35) (43) 83.7 (55) 47.9 (32) 31.7 (21) 41.0 (25) month s (121) (75) (60) (48) 70.6 (32) (24) 66.2 (30) 44.1 (20) 28.9 (13) 64.0 (29) month s (72) (47) (41) (40) 63.8 (20) (19) 57.4 (18) 54.2 (17) 28.9 (9) 44.6 (14) month s (99) (61) (56) 86.8 (33) 44.3 (17) (19) 93.9 (36) 60.0 (23) 21.0 (8) 36.5 (14) >60 month s (66) (49) (42) (40) 59.6 (16) (13) 93.2 (25) 67.1 (18) 30.1 (8) 74.6 (20)
24 Cumul ative Dose 1 90 mg (129) (92) (90) (72) 51.4 (34) (43) 82.9 (54) 43.1 (28) 30.8 (20) 45.8 (28) 9,1 25,0 mg (167) (98) (81) (70) 67.4 (44) (38) 61.8 (40) 56.7 (37) 27.8 (18) 52.1 (34) 25,1 50,0 mg (109) (77) (61) (56) 62.4 (28) (19) 84.7 (38) 51.2 (23) 26.9 (12) 46.8 (21) 50, 1 mg (71) (53) (50) (35) 42.7 (14) (18) 97.6 (32) 67.1 (22) 27.7 (9) 57.9 (19)
25 etable 11. Adjusted a Hazad Ratios fo Eve Use of Pioglitazone and othe diabetes medications and Risk of Ca of the Postate, Female Beast, Lung/Bonchus and Colon, nonhodgkin Lymphoma, Copus Utei, Paas, Kidney/Renal Pelvis, and Rectum and Melanoma: Kaise Pemanente Nothen Califonia Diabetes Registy, Post ate Adjusted a Hazad Ratios Confide Intevals) Fem ale Bea st Lung/ Bonc hus Colo n NHL Cop us Utei Panc eas Kidn ey/ Rena l Pelvi s Rect um Melano ma Pesons with 3,777 2,574 2, Ca 2,797 Eve Pioglitazone b ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) Eve Othe TZD (0.71 (0.73 (0.68 (0.80 (0.75 (0.91 (0.92 (0.89 (0.44 ( ) 1.19) 1.66) 1.89) 2.02) 1.49) 1.97) 1.21) 1.41) 1.88) Eve Metfomin (0.99 (0.86 (0.81 (0.83 (0.91 (0.90 (1.02 (0.90 (0.82 ( ) 0.98) 1.26) 1.43) 1.28) 1.22) 1.15) 1.04) 1.03) 1.25) Eve Insulin (0.81 (0.97 (1.08 (0.90 (0.76 (0.84 (1.97 (0.91 (0.75 ( ) 1.35) 1.10) 2.78) 1.35) 1.21) 1.23) 1.21) 1.16) 1.20) Eve Sulfonylueas (0.86 (0.88 (0.99 (0.96 (0.82 (0.91 (1.22 (0.84 (0.90 ( ) 1.24) 1.18) 1.81) 1.23) 1.44) 1.32) 1.08) 1.24) 1.30) Eve Othe OHA (0.61 (0.41 (0.78 (0.55 (1.10 (0.44 (0.71 (0.56 (0.39 ( ) 1.49) 2.52) 1.74) 1.70) 1.76) 1.96) 0.88) 1.21) 1.32) Neve diabetes dug pesciption (0.84 (0.84 (0.84 (0.73 (0.75 (0.76 (0.54 (0.82 (0.81 ( ) 1.14) 1.25) 1.02) 1.42) 1.53) 1.38) 1.13) 1.03) 1.30) Neve 2 same dug pesciptions (0.99 (0.72 (0.81 (0.81 (0.82 (0.58 (1.02 (0.43 (0.71 ( ) 1.28) 1.69) 2.36) 1.14) 1.78) 1.98) 1.14) 1.35) 1.34) a Hazad Ratios ae adjusted fo age, eve use of othe diabetes medications, yea of cohot enty, sex, aceethnicity, income, cuent smoking, baseline HbA1c, diabetes duation, new diabetes osis, ceatinine and congestive heat failue. b Neve use of pioglitazone as efee goup. Identical method was used to detemine the HR of othe diabetes medications. NHL = NonHodgkin lymphoma TZD = Thiazolidinedione OHA = Oal hypoglycemic agent
INDIVIDUALIZATION FEATURE OF HEAD-RELATED TRANSFER FUNCTIONS BASED ON SUBJECTIVE EVALUATION. Satoshi Yairi, Yukio Iwaya and Yôiti Suzuki
INDIVIDUALIZATION FEATURE OF HEAD-RELATED TRANSFER FUNCTIONS BASED ON SUBJECTIVE EVALUATION Satoshi Yaii, Yukio Iwaya and Yôiti Suzuki Reseach Institute of Electical Communication / Gaduate School of Infomation
More informationStochastic Extension of the Attention-Selection System for the icub
Stochastic Extension of the Attention-Selection System fo the icub Technical Repot (in pepaation) H. Matinez, M. Lungaella, and R. Pfeife Atificial Intelligence Laboatoy Depatment of Infomatics Univesity
More informationThe Probability of Disease. William J. Long. Cambridge, MA hospital admitting door (or doctors oce, or appropriate
Repinted fom Poceedings of the Fifteenth Annual Symposium on Compute Applications in Medical Cae, pp 619-623, 1991 The Pobability of Disease William J. Long MIT Laboatoy fo Compute Science Cambidge, MA
More informationPrevalence and Correlates of Diabetes Mellitus Among Adult Obese Saudis in Al-Jouf Region
Wold Jounal of Public Health 2017; 2(2): 81-88 http://www.sciencepublishinggoup.com/j/wjph doi: 10.11648/j.wjph.20170202.14 Pevalence and Coelates of Diabetes Mellitus Among Adult Obese Saudis in Al-Jouf
More informationTechnical and Economic Analyses of Poultry Production in the UAE: Utilizing an Evaluation of Poultry Industry Feeds and a Cross-Section Survey
Available online at www.sciencediect.com ScienceDiect APCBEE Pocedia 8 (2014 ) 266 271 2013 4th Intenational Confeence on Agicultue and Animal Science (CAAS 2013) 2013 3d Intenational Confeence on Asia
More informationDietary Assessment in Epidemiology: Comparison of a Food Frequency and a Diet History Questionnaire with a 7-Day Food Record
Ameican Jounal of Epidemiology Copyight O 996 by The Johns Hopkins Univesity School of Hygiene and Public Health All ights eseved Vol. 4, No. 9 Pinted In U.SJU. Dietay Assessment in Epidemiology: Compaison
More informationInterpreting Effect Sizes in Contrast Analysis
UNDERSTANDING STATISTICS, 3(1), 1 5 Copyight 004, Lawence Elbaum Associates, Inc. TEACHING ARTICLES Intepeting Effect Sizes in Contast Analysis R. Michael Fu Depatment of Psychology Appalachian State Univesity
More informationInfluencing Factors on Fertility Intention of Women University Students: Based on the Theory of Planned Behavior
Vol.32 (Healthcae and Nusing 206), pp.37-42 http://dx.doi.og/0.4257/astl.206. Influencing Factos on Fetility Intention of Women Univesity Students: Based on the Theoy of Planned Behavio Myeong-Jeong Chae,
More informationRelationship of Mammographic Parenchymal Patterns with Breast Cancer Risk Factors and Risk of Breast Cancer in a Prospective Study
Intenational Jounal of Epidemiology Intenational Epidemiological Association 1990 Vol. 19, No. 2 Pinted in Geat Bitain Relationship of Mammogaphic Paenchymal Pattens with Beast Cance Risk Factos and Risk
More informationOsteoarthritis and Cartilage 19 (2011) 58e64
Osteoathitis and Catilage 19 (2011) 58e64 Does measuement of the anatomic axis consistently pedict hip-knee-ankle angle (HKA) fo knee alignment studies in osteoathitis? Analysis of long limb adiogaphs
More informationI Can PresCribE A Drug: Mnemonic-based Teaching of Rational Prescribing
236 Apil 2007 Family Medicine Fo the Office-based Teache of Family Medicine William Huang, MD Featue Edito Edito s Note: In this month s column, Kal Igla, MD; Natalie Kennie, PhamD; and Jana Bajca, MScPham,
More informationRadiation Protection Dosimetry, Volume II: Technical and Management System Requirements for Dosimetry Services. REGDOC-2.7.
Radiation Potection Dosimety, Volume II: Technical and Management System Requiements fo Dosimety Sevices REGDOC-2.7.2, Volume II Apil 2018 Dosimety, Volume II: Regulatoy document REGDOC-2.7.2, Volume II
More informationDistress is an unpleasant experience of an emotional,
Featue Aticle Distess Assessment: Pactice Change Though Guideline Implementation Cayl D. Fulche, MSN, APRN, BC, and Tacy K. Gosselin-Acomb, RN, MSN, AOCN Most nuses agee that incopoating evidence into
More informationMultiscale Model of Oxygen transport in Diabetes
BENG 221: Poblem Solving Poject Multiscale Model of Oxygen tanspot in Diabetes Decembe 1, 2016 Austin Budick Nafeesa Khan Sihita Rudaaju Motivation Diabetes emains a significant health condition today,
More informationBy: Charlene K. Baker, Fran H. Norris, Eric C. Jones and Arthur D. Murphy
Childhood Tauma and Adulthood Physical Health in Mexico. By: Chalene K. Bake, Fan H. Nois, Eic C. Jones and Athu D. Muphy C.K. Bake, F.H. Nois, E.C. Jones and A.D. Muphy. Childhood Tauma and Adulthood
More informationCould changes in national tuberculosis vaccination policies be ill-informed?
Math. Model. Nat. Phenom. Vol. 7, No. 3, 2012, pp. 78 98 DOI: 10.1051/mmnp/20127307 Could changes in national tubeculosis vaccination policies be ill-infomed? D. J. Gebey 1, F. A. Milne 2 1 Depatment of
More informationAPPLICATION OF THE WALSH TRANSFORM IN AN INTEGRATED ALGORITHM FO R THE DETECTION OF INTERICTAL SPIKES
APPLICATIO OF THE WALSH TRASFORM I A ITEGRATED ALGORITHM FO R THE DETECTIO OF ITERICTAL SPIKES D. Sanchez, M. Adjouadi, A. Baeto, P. Jayaka, I. Yaylali Electical & Compute Engineeing, Floida Intenational
More informationGLOBAL PARTNERSHIP FOR YOUTH EMPLOYMENT. Testing What Works. Evaluating Kenya s Ninaweza Program
GLOBAL PARTNERSHIP FOR YOUTH EMPLOYMENT Testing What Woks in Youth Employment: Evaluating Kenya s Ninaweza Pogam VOLUME 2: Appendices APRIL 2013 acknowledgements This epot was pepaed fo IYF by Thomaz Alvaes
More informationEating behavior traits and sleep as determinants of weight loss in overweight and obese adults
OPEN Citation: Nutition & Diabetes (2014) 4, e140; doi:10.1038/nutd.2014.37 2014 Macmillan Publishes Limited All ights eseved 2044-4052/14 www.natue.com/nutd ORIGINAL ARTICLE Eating behavio taits and sleep
More informationAutologous Transplant Patient Education Guide
Autologous Tansplant Patient Education Guide Blood & Maow Tansplant Pogam Taussig Cance Institute Copyight 1995-2015 The Cleveland Clinic Foundation. All ights eseved. Definitions of Tems Table of Contents
More informationTest Retest and Between-Site Reliability in a Multicenter fmri Study
Human Bain Mapping 29:958 972 (2008) Test Retest and Between-Site Reliability in a Multicente fmri Study Lee Fiedman, 1 * Hal Sten, 2 Gegoy G. Bown, 3 Daniel H. Mathalon, 4 Jessica Tune, 1 Gay H. Glove,
More informationCommissioning for Value Where to Look pack
Commissioning fo Value Whee to Look pack Suffolk and Noth East Essex - STP aea Decembe 2016 Neuological Apil 2016 Contents Intoduction to you Whee to Look pack Suppoting the STP pocess NHS RightCae and
More informationWhy do we remember some things and not others? Consider
Attention pomotes episodic encoding by stabilizing hippocampal epesentations Maiam Aly a,1 and Nicholas B. Tuk-Bowne a,b a Pinceton Neuoscience Institute, Pinceton Univesity, Pinceton, NJ 08544; and b
More informationSMARTPHONE-BASED USER ACTIVITY RECOGNITION METHOD FOR HEALTH REMOTE MONITORING APPLICATIONS
SMARTPHONE-BASED USER ACTIVITY RECOGNITION METHOD FOR HEALTH REMOTE MONITORING APPLICATIONS Igo Bisio Fabio Lavagetto Maio Machese Andea Sciaone Univesity of Genoa DYNATECH {igo.bisio fabio.lavagetto maio.machese
More informationlsokinetic Measurements of Trunk Extension and Flexion Performance Collected with the Biodex Clinical Data Station
lsokinetic Measuements of Tunk Extension and Flexion Pefomance Collected with the Biodex Clinical Data Station MARK D. GRABINER, PhD,' JOHN J. JEZIOROWSKI, MS, PT,' ARUNA D. DIVEKAR, MS, PT' Jounal of
More informationCHAPTER 1 BACKGROUND ON THE EPIDEMIOLOGY AND MODELING OF BIV/AIDS
CHAPTER 1 BACKGROUD O THE EPDEMOLOGY AD MODELG OF BV/ADS Befoe modeling any disease it is cucial to undestand the epidemiological featues of the disease. The fist fou sections of this chapte pesent epidemiological
More informationFinal Report 22 January 2014
Final Report 22 January 2014 Cohort Study of Pioglitazone and Cancer Incidence in Patients with Diabetes Mellitus, Follow-up 1997-2012 Kaiser Permanente Division of Research Assiamira Ferrara, MD, Ph.D.
More informationObjective Find the Coefficient of Determination and be able to interpret it. Be able to read and use computer printouts to do regression.
Section 3.C Objective Find the Coefficient of Detemination and be able to intepet it. Be able to ead and use compute pintouts to do egession. Relevance To be able to find a model to best epesent quantitative
More informationAlternative Methods of Insulin Sensitivity Assessment in Obese Children and Adolescents
Diabetes Cae Publish Ahead of Pint, published online Januay 17, 2008 Altenative Methods of Insulin Sensitivity Assessment in Obese Childen and Adolescents Sophia M Rössne, MD, (1); Matin Neovius, PhD,
More informationReliability and Validity of the Korean Version of the Cancer Stigma Scale
ORIGINAL ARTICLE ISSN (Pint) 2005-3673 ISSN (Online) 2093-758X J Koean Acad Nus Vol.47 No.1, 121 Reliability and Validity of the Koean Vesion of the Cance Stigma Scale So, Hyang Sook 1 Chae, Myeong Jeong
More informationPOLINA EIDELMAN 1, LISA S. TALBOT 1, JUNE GRUBER 1, ILANA
J. Sleep Res. (2010) 19, 516 524 Sleep and bipola disode doi: 10.1111/j.1365-2869.2010.00826.x Sleep achitectue as coelate and pedicto of symptoms and impaiment in inte-episode bipola disode: taking on
More informationVIII. FOOD AND llutrielfl' COMPOSITION OF SBP MEALS
VIII. FOOD AND llutrielfl' COMPOSITION OF SBP MEALS This chapte pesents esults of the analysis of data gatheed in the on-site meal obsevations. The analysis examines the food and nutient composition of
More informationPublished: 10/06/2014. Arrhythmia Pathway
Ahythmia Pathway Pa%ent pesents with symptoms, palpita%ons, chest pain, dyspnoea, syncope/pe syncope, asymptoma%c Suspected Ahythmia Pathway Diagnosis Management Page 1 of 4 Review of esults to detemine
More informationMIRCERA DESCRIPTION. Methoxy polyethylene glycol-epoetin beta. CAS registry number:
Copy fom GRASS MIRCERA Methoxy polyethylene glycol-epoetin beta CAS egisty numbe: 677324-53-7 DESCRIPTION MIRCERA (methoxy polyethylene glycol-epoetin beta) is a chemically synthesised Eythopoiesis Stimulating
More informationNadine Gaab, 1,2 * John D.E. Gabrieli, 1 and Gary H. Glover 2 INTRODUCTION. Human Brain Mapping 28: (2007) r
Human Bain Mapping 28:703 720 (2007) Assessing the Influence of Scanne Backgound Noise on Auditoy Pocessing. I. An fmri Study Compaing Thee Expeimental Designs with Vaying Degees of Scanne Noise Nadine
More informationStable angina: drugs, angioplasty or surgery?
Euopean Heat Jounal (997) 8 {Supplement B), B2-B Stable angina: dugs, angioplasty o sugey? G.Jackson Guy's Hospital, London, U.K. Stable angina is a common condition with a good oveall pognosis and annual
More informationJournal of Applied Science and Agriculture
Jounal of Applied Science and Agicultue, 9(1) Januay 2014, Pages: 171-176 AENSI Jounals Jounal of Applied Science and Agicultue ISSN 1816-9112 Jounal home page: www.aensiweb.com/jasa/index.html The Relationship
More informationMIRCERA DESCRIPTION. Methoxy polyethylene glycol-epoetin beta. CAS registry number:
Copy fom GRASS MIRCERA Methoxy polyethylene glycol-epoetin beta CAS egisty numbe: 677324-53-7 DESCRIPTION MIRCERA (methoxy polyethylene glycol-epoetin beta) is a chemically synthesised Eythopoiesis Stimulating
More informationThe Egyptian Journal of Hospital Medicine (January 2018) Vol. 70, Page
The Egyptian Jounal of Hospital Medicine (Januay 2018) Vol. 70, age 109-113 Coelation between Cental Coneal Thickness and Degee of Myopia Mostafa A, Mohamed M, Mohamed M. Al Hussein Univesity Hospital
More informationStacy R. Tomas, David Scott and John L. Crompton. Department of Recreation, Park and Tourism Sciences, Texas A&M University, USA
Managing Leisue 7, 239 250 (2002) An investigation of the elationships between quality of sevice pefomance, benefits sought, satisfaction and futue intention to visit among visitos to a zoo Stacy R. Tomas,
More informationShunting Inhibition Controls the Gain Modulation Mediated by Asynchronous Neurotransmitter Release in Early Development
Shunting Inhibition Contols the Gain Modulation Mediated by Asynchonous Neuotansmitte Release in Ealy Development Vladislav Volman 1,2,3 *, Hebet Levine 1, Teence J. Sejnowski 1,2,3,4 1 Cente fo Theoetical
More informationChasing the AIDS Virus
doi:10.1145/1666420.1666440 With no HI vaccine in sight, viologists need to know how the vius will eact to a given combination dug theapy. by Thomas Lengaue, Andé Altmann, Alexande Thielen, and Rolf Kaise
More informationThe association between obesity and cardiac output (CO)
Relations of Stoke Volume and Cadiac Output to Body Composition The Stong Heat Study Taquin Collis, MD; Richad B. Deveeux, MD; May J. Roman, MD; Giovanni de Simone, MD; Jeun-Liang Yeh, PhD; Babaa V. Howad,
More informationQUEEN CONCH STOCK RESTORATION
QUEEN CONCH STOCK RESTORATION Robet Glaze Associate Reseach Scientist Floida Maine Reseach Institute South Floida Regional Laboatoy Maathon, Floida INTRODUCTION Queen conch ae found in pedominantly south
More informationAnalysis on Retrospective Cardiac Disorder Using Statistical Analysis and Data Mining Techniques
Intenational Jounal of Applied Engineeing Reseach ISSN 0973-456 Volume 1, Numbe 17 (017) pp. 6778-6787 Analysis on Retospective Cadiac Disode Using Statistical Analysis and Data Mining Techniques Jyotismita
More informationAllogeneic Reduced Intensity Transplant Patient Education Binder
Allogeneic Reduced Intensity Tansplant Patient Education Binde Blood & Maow Tansplant Pogam Taussig Cance Institute Copyight 1995-2013 The Cleveland Clinic Foundation. All ights eseved. Definitions of
More informationAppendix 1. Post - Chernobyl Thyroid Cancer in Ukraine
Appendix 1 Post - Chenobyl Thyoid Cance in Ukaine POST- CHERNOBYL THYROID CANCER IN UKRAINE. REPORT 1: Estimation of thyoid doses. 1 I. Likhtaov, 1 L. Kovgan, 1 S. Vavilov, 1 M. Chepuny, 2 A. Bouville,
More informationInstructions For Living a Healthy Life
ARISE Homo Sapiens Opeato s Manual: Instuctions Fo Living a Healthy Life Table of Contents Tips fo Teaching ARISE Life Management Skills...3 ARISE Foundation, Ode Toll-Fee: 1-888-680-6100, Copyight 1996-2014
More informationSimulation of the Human Glucose Metabolism Using Fuzzy Arithmetic
Simulation of the uman Glucose Metabolism Using uy Aithmetic Michael anss live Nehls Institute A of Mechanics Univesity of Stuttgat Pfaffenwalding 9 755 Stuttgat Gemany ManssNehls @mechaunistuttgatde Abstact
More informationHTGR simulations in PSI using MELCOR 2.2
WIR SCHAFFEN WISSEN HEUTE FÜR MORGEN Jamo Kalilainen :: Paul Schee Institut HTGR simulations in PSI using MELCOR 2.2 10 th Meeting of the Euopean MELCOR Use Goup (EMUG), 25 27 Apil, Zage, Coatia Intoduction
More informationThe hypothesis that a behavioral intervention augments
Behavioal Neuocadiac Taining in Hypetension A Randomized, Contolled Tial Robet P. Nolan, John S. Floas, Paula J. Havey, Makad V. Kamath, Pete E. Picton, Caoline Chessex, Natalie Hiscock, Jonathan Powell,
More informationEvaluation of the accuracy of Lachman and Anterior Drawer Tests with KT1000 ın the follow-up of anterior cruciate ligament surgery
Oiginal Aticle Jounal of Execise Rehabilitation 2016;12(4):363-367 Evaluation of the accuacy of Lachman and Anteio Dawe Tests with KT1000 ın the follow-up of anteio cuciate ligament sugey Beki Eay Kilinc
More informationPredictors of Maternal Identity of Korean Primiparas
J Koean Acad Nus Vol.4 No.6, 733-74 http://dx.doi.og/0.4040/jkan.20.4.6.733 Pedictos of Matenal Identity of Koean Pimipaas Chae, Hyun-Ju Song, Ju-Eun 2 Kim, Sue 3 Pat-time Lectue, College of Nusing, Sungshin
More informationThe Only One-Injection Treatment for up to 6 months of Osteoarthritis Knee Pain Relief
The Only One-Injection Teatment fo up to 6 months of Osteoathitis Knee Pain Relief What is Synvisc-One? Synvisc-One is fo patients who have tied diet, execise and ove-thecounte pain medicines and still
More informationE - Staff availability issues. Delays
Date of Pemiss ion Fist Recuit ed? Date of Fist Recuited Duation between VRA Pemission Duation between Pemission Fist Duatio n betwee n VRA Fist Benchmak Met A - Pemissions delayed/denied B - Suspended
More informationA Brain-Machine Interface Enables Bimanual Arm Movements in Monkeys
BRIN-MHINE INTERFES Bain-Machine Inteface Enables Bimanual m Movements in Monkeys Pete J. Ifft, 1,2 Solaiman Shoku, 2,3 Zheng Li, 2,4 Mikhail. Lebedev, 2,4 Miguel. L. Nicolelis 1,2,4,5,6 * Bain-machine
More informationFUNCTIONAL MAGNETIC RESONANCE IMAGING OF LANGUAGE PROCESSING AND ITS PHARMACOLOGICAL MODULATION DISSERTATION
FUNCTIONAL MAGNETIC RESONANCE IMAGING OF LANGUAGE ROCESSING AND ITS HARMACOLOGICAL MODULATION DISSERTATION esented in atial Fulfillment of the Requiements fo the Degee Docto of hilosophy in the Gaduate
More informationAdaptive and Context-Aware Privacy Preservation Schemes Exploiting User Interactions in Pervasive Environments
Adaptive and Context-Awae Pivacy Pesevation Schemes Exploiting Use Inteactions in Pevasive Envionments Gautham Pallapa*, Maio Di Fancesco t *, and Sajal K. Das* *Cente fo Reseach in Wieless Mobility and
More informationThe Effects of Rear-Wheel Camber on Maximal Effort Mobility Performance in Wheelchair Athletes
Taining & Testing 199 The Effects of Rea-Wheel Cambe on Maximal Effot Mobility Pefomance in Wheelchai Athletes Authos B. Mason 1, L. van de Woude 2, K. Tolfey 1, V. Goosey-Tolfey 1 Affiliations 1 Loughboough
More informationSexual arousal and the quality of semen produced by masturbation
Human Repoduction vol.11 no.l pp.147-151, 1996 Sexual aousal and the quality of semen poduced by mastubation J.H.van Roijen 14 ' 5, A.K.Slob 4, W.L.Gianotten 2, G.R.Dohle 1 ' 3, A.T.M.van de Zon 2, J.T.M.Veebug
More informationAnnual General Meeting of Shareholders of Roche Holding Ltd 27 February 2006
Annual Geneal Meeting of Shaeholdes of Roche Holding Ltd 27 Febuay 2006 Addess by Jan van Koeveinge Head Phama Global Technical Opeations (The addess as deliveed is definitive.) Addess by Jan van Koeveinge
More informationPEKKA KANNUS, MD* Downloaded from at on April 8, For personal use only. No other uses without permission.
0196-6011/88/1003-0097$02.00/0 THE OURNAL OF ORTHOPAEDIC AND SPORTS PHYSICAL THERAPY Copyight 0 1988 by The Othopaedic and Spots Physical Theapy Sections of the Ameican Physical Theapy Association Peak
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repositoy of the Radboud Univesity Nijmegen The following full text is a publishe's vesion. Fo additional infomation about this publication click this link. http://hdl.handle.net/2066/23072
More informationAbstract. Background and objectives
Poceedings - 7th Intenational Wokshop on Biological Effects of EMF - Octobe 01 (Malta) ISBN: 978-99957-0-361-5 MORPHOLOGICAL TRANSFORMATIONS OF HUMAN CANCER CELLS AND MICROTUBULES CAUSED BY FREQUENCY SPECIFIC
More informationCoach on Call. Thank you for your interest in When the Scale Does Not Budge. I hope you find this tip sheet helpful.
Coach on Call It was geat to talk with you. Thank you fo you inteest in. I hope you find this tip sheet helpful. Please give me a call if you have moe questions about this o othe topics. As you UPMC Health
More informationThe Engagement of Mid-Ventrolateral Prefrontal Cortex and Posterior Brain Regions in Intentional Cognitive Activity
Human Bain Mapping 29:107 119 (2008) The Engagement of Mid-Ventolateal Pefontal Cotex and Posteio Bain Regions in Intentional Cognitive Activity Anja Dove, 1 Tom Manly, 1 Russell Epstein, 2 and Adian M.
More informationA Mathematical Model of The Effect of Immuno-Stimulants On The Immune Response To HIV Infection
Intenational Jounal of Latest Engineeing Reseach and Applications (IJLERA) ISSN: 455-7137 A Mathematical Model of The Effect of Immuno-Stimulants On The Immune Response To HIV Infection *iwa P. 1, Rotich
More informationSystolic and Pipelined. Processors
Gaduate Institute of Electonics Engineeing, NTU Systolic and Pipelined Why Systolic Pocessos Achitectue? Souces: VLSI Signal Pocessing ÜÜ Ande Hon, Jason Handube, Michelle Gunning, Beman, J. Kim, Heiko
More informationThe Impact of College Experience on Future Job Seekers Diversity Readiness
Intenational Jounal of Humanities and Social Science Vol. 3 No. 3; Febuay 2013 The Impact of College Expeience on Futue Job Seekes Divesity Readiness FELICE A. WILLIAS Louisiana State Univesity - Shevepot
More informationAdvanced Placement Psychology Grades 11 or 12
Office of Cuiculum & Instuction Advanced Placement Psychology Gades 11 o 12 ABSTRACT The pupose of AP Psychology is to intoduce students to the systematic and scientific study of the behavio and mental
More informationMETHODS FOR DETERMINING THE TAKE-OFF SPEED OF LAUNCHERS FOR UNMANNED AERIAL VEHICLES
Jounal of KONES Powetain and Tanspot, Vol. 25, No. 1 2018 METHODS FOR DETERMINING THE TAKE-OFF SPEED OF LAUNCHERS FOR UNMANNED AERIAL VEHICLES Gzegoz Jastzębski, Leszek Ułanowicz Ai Foce Institute of Technology
More informationIn addition to the threat of high morbidity
HEALTH SEVICES Hospital capacity and management pepaedness fo pandemic influenza in Victoia Ben Dewa, 1 Ian Ba, 2 Piscilla obinson 1 In addition to the theat of high mobidity and motality, influenza pandemics
More informationCausal Beliefs Influence the Perception of Temporal Order
ausal eliefs Influence the Peception of Tempoal Ode Philip M. Fenbach (philip_fenbach@bown.edu) Peston LinsonGenty (peston_linsongenty@bown.edu) Steven. Sloman (steven_sloman@bown.edu) own Univesity, Depatment
More informationIRPPS Working Papers. The regional distribution of in-hospital fatality among Acute Myocardial Infarction events in Italy
IRPPS Woking Papes Istituto di Riceche sulla Popolazione e le Politiche Sociali - CNR ISSN 2240-7332 The egional distibution of in-hospital fatality among Acute Myocadial Infaction events in Italy Anna
More informationTwo universal runoff yield models: SCS vs. LCM
J. Geog. Sci. 2015, 25(3): 311-318 DOI: 10.1007/s11442-015-1170-2 2015 Science Pess Spinge-Velag Two univesal unoff yield models: SCS vs. LCM LI Jun, * LIU Changming, WANG Zhonggen, LIANG Kang Key Laboatoy
More informationProtecting Location Privacy: Optimal Strategy against Localization Attacks
Potecting Location Pivacy: Optimal Stategy against Localization Attacks Reza Shoki, Geoge Theodoakopoulos, Camela Toncoso, Jean-Piee Hubaux, and Jean-Yves Le Boudec LCA, EPFL, Lausanne, Switzeland, ESAT/COSIC,
More informationThe number and width of CT detector rows determine the
Iodinated Contast Opacification s in Nomal Coonay Ateies Imaged With Pospectively ECG-Gated Single Heat Beat 320-Detecto Row Computed Tomogaphy Michael L. Steigne, MD; Dimitios Mitsouas, PhD; Amanda G.
More informationApplication Of Fuzzy Logic Controller For Intensive Insulin Therapy In Tpye 1 Diabetic Mellitus Patient
COMPUTERS and SMULATON in MOERN SCENCE, Volume Application Of Fuzzy Logic Contolle Fo ntensive nsulin Theapy n Tpye iabetic Mellitus Patient LALEH KARAR *, AL FALLAH, Shahia Ghaibzadeh, Fatollah Moztazadeh
More informationMeasurement uncertainty of ester number, acid number and patchouli alcohol of patchouli oil produced in Yogyakarta
Measuement uncetainty of este numbe, acid numbe and patchouli alcohol of patchouli oil poduced in Yogyakata Reni Banowati Istiningum, Azis Saepuloh, Widatul Jannah, and Didit Waskito Aji Citation: AIP
More informationElectronic Supplementary Information
Electonic upplementay Mateial (EI) fo Geen Chemisty. This jounal is The Royal ociety of Chemisty Electonic upplementay Infomation Cack healing and eclaiming of vulcanized ubbe by tiggeing eaangement of
More informationOPTIMUM AUTOFRETTAGE PRESSURE IN THICK CYLINDERS
Junal Meanial Decembe 007, No. 4, - 4 OTIMUM AUTOFRETTAGE RESSURE IN THICK CLINDERS Aman Ayob *, M. Kabashi Elbashee Depatment of Applied Mechanics, Faculty of Mechanical Engineeing, Univesiti Tenologi
More informationF1 generation: The first set of offspring from the original parents being crossed. F2 generation: The second generation of offspring.
Padon the Punnett By: Nancy Volk The Punnett Squae This module stems fom the wok of the Austian Monk, Gego Mendel, the fathe of genetics. In the mid-1800s Mendel studied the pattens of inheitance of physical
More informationTAMIFLU oseltamivir phosphate
NAME OF THE MEDICINE TAMIFLU oseltamivi phosphate (CAS egisty numbe: 204255-11-8) O COOC 2 H 5 O HN NH. 2 H 3 PO 4 The chemical name (3R,4R,5S)-4-acetylamino-5-amino-3-(1-ethylpopoxy)-1-cyclohexene-1-
More informationBurden of Chinese Stroke Family Caregivers: The Hong Kong Experience
1462 ORIGINAL ARTICLE Buden of Chinese Stoke Family : The Hong Kong Expeience Wai-Kwong Tang, MD, Chieh G. Lau, BSc, Vincent Mok, MD, Gabo S. Ungvai, MD, Ka-Sing Wong, MD ABSTRACT. Tang W-K, Lau CG, Mok
More informationpneumonia from the Pediatric Clinic of the University of Padua. Serological Methods
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 56 (1983), 517-521 Seodiagnosis of M. pneumoniae Infections by Enzyme- Linked Immunosobent Assay (ELISA) FRANCO BUSOLO, M.D., AND GIOVANNI ANTONIO MELONI, M.D.
More informationUnsuccessful Use of Binaural Amplification by an Elderly Person
J Am Acad Audiol 8 : 1-1 (1997) Unsuccessful Use of Binaual Amplification by an Eldely Peson Rose Chmiel* James Jege* Emily Muphy* Fancis Piozzolot Caolyn Tooley-Young* Abstact An eldely peson who pefeed
More informationCollaborative Evaluation of a Fluorometric Method for Measuring Alkaline Phosphatase Activity in Cow s, Sheep s, and Goat s Milk
Jounal of Food Potection, Vol., No., 00, Pages Copyight, Intenational Association fo Food Potection Collaboative Evaluation of a Fluoometic Method fo Measuing Alkaline Phosphatase Activity in Cow s, Sheep
More informationS[NCE the publication of The Authoritarian
AUTHORITARIAN ATTITUDES AND PERSONALITY MALADJUSTMENT ARTHUR R. JENSEN 1 Institute of Psychiaty (Maudstey Hospital], Univesity of London S[NCE the publication of The Authoitaian Pesonality (2), the elationship
More informationRIGHT VENTRICULAR INFARCTION - CLINICAL, HAEMODYNAMIC, ECHOCARDIOGRAPHIC AND THERAPEUTIC CONSIDERATIONS
RIGHT VENTRICULAR INFARCTION - CLINICAL, HAEMODYNAMIC, ECHOCARDIOGRAPHIC AND THERAPEUTIC CONSIDERATIONS A T H Tan B L Chia B K H Ee M Choo SYNOPSIS Right venticula infaction complicating infaction of the
More informationSEE DRAWING OF ROOM LAYOUT ATTACHMENT FOR SPEAKERS
2018 Emegency Symposium 2. Incident Numbe: 4. Map/Sketch (include sketch, showing the total aea of opeations, the incident site/aea, impacted and theatened aeas, oveflight esults, tajectoies, impacted
More informationThe Regional Economics Applications Laboratory (REAL) of the University of Illinois focuses on the development and use of analytical models for urban
The Regional Economics Applications Laboatoy (REAL) of the Univesity of Illinois focuses on the development and use of analytical models fo uban and egional economic development. The pupose of the Discussion
More informationREVIEWS 1. Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?
Does the mobilization of ciculating tumou cells duing cance theapy cause metastasis? Olga A. Matin 1,2,4, Robin L. Andeson 3,4, Kailash Naayan 1,4,5 and Michael P. MacManus 1,4 Abstact Despite pogessive
More informationAssessment of postural balance in multiple sclerosis patients
Atteya et al. The Egyptian Jounal of Neuology, Psychiaty and Neuosugey (2019) 55:7 https://doi.og/10.1186/s41983-018-0049-4 The Egyptian Jounal of Neuology, Psychiaty and Neuosugey RESEARCH Open Access
More informationP states that is often characterized by an acute blood and
In Vivo Administation of Antibody to Inteleukin-5 Inhibits Inceased Geneation of Eosinophils and Thei Pogenitos in Bone Maow of Paasitized Mice By Donna M. Rennick, LuAnn Thompson-Snipes, Robet L. Coffman,
More informationNEOTIGASON NAME OF THE MEDICINE. acitretin
NAME OF THE MEDICINE NEOTIGASON acitetin CAS Registy Numbe: 55079-83-9 DESCRIPTION NEOTIGASON (acitetin) is a etinoid fo the oal teatment of sevee cases of psoiasis and disodes of keatinisation. It is
More informationVisual stimulus locking of EEG is modulated by temporal congruency of auditory stimuli
DOI 1.17/s221-9-1867-5 RESEARCH ARTICLE Visual stimulus locking of EEG is modulated by tempoal conguency of auditoy stimuli Sonja Schall Cliodhna Quigley Selim Onat Pete König Received: 16 Octobe 28 /
More informationEffect of Hydroxymethylated Experiment on Complexing Capacity of Sodium Lignosulfonate Ting Zhou
3d Intenational Confeence on Mateial, Mechanical and Manufactuing Engineeing (IC3ME 15) Effect of Hydoxymethylated Expeiment on Complexing Capacity of Sodium Lignosulfonate Ting Zhou School of Nuclea Technology
More informationStructural Safety. Copula-based approaches for evaluating slope reliability under incomplete probability information
Stuctual Safety 52 (2015) 90 99 Contents lists available at ScienceDiect Stuctual Safety jounal homepage: www.elsevie.com/locate/stusafe Copula-based appoaches fo evaluating slope eliability unde incomplete
More informationAntibodies to Saccharomyces cerevisiae in patients
Gut 1992; 33:171-175 Gastoenteology Unit, M H Giaffe C D Holdswoth and Univesity of Sheffield Medical School, Depatment of Clinical and Expeimental Micobiology, Royal Hallamshie Hospital, Sheffield A Clak
More information